跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
anti-CEA antibody (cancer)
首页
药物
anti-CEA antibody (cancer)
anti-CEA antibody (cancer)
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Anti-idiotype anti-cea antibody molecules and its use as cancer vaccine
申请人: CARTER GRAHAM
优先权: 2002
US
IMMUNOCONJUGATES COMPRISING AN ANTI-CEA ANTIBODY LINKED BY CONJUGATION TO ONE OR MORE 8-HET-2- AMINOBENZAZEPINE DERIVATIVES USEFUL IN TREATING CANCER
申请人: BOLT BIOTHERAPEUTICS INC
优先权: 2020
CN
EP
US
WO
5 件公开
Monoclonal Antibodies Against Carcinoembryonic Antigens, and Their Uses
申请人: AMERICAN DIAGNOSTICS & THERAPY LLC ADXRX
优先权: 2022
US
2 件公开
Monoclonal antibody against anticancer embryonic antigen and application thereof
申请人: US DIAGNOSTICS AND THERAPEUTICS LLC
优先权: 2022
CN
ANTI-CEA ANTIBODIES
申请人: PHILOGEN SPA
优先权: 2023
US
WO
2 件公开
Nano-antibody combination for detecting carcino-embryonic antigen by double-antibody sandwich method
申请人: SHENZHEN INNOVA NANOBODI CO LTD
优先权: 2019
CN
HUMANIZED ANTI-CEACAM5 ANTIBODY AND USES THEREOF
申请人: IMMUNOMEDICS INC
优先权: 2014
US
Monoclonal antibody to CEA, conjugates comprising said antibody and their therapeutic use
申请人: ASTRAZENECA UK LTD
优先权: 2001
US
2 件公开
药物
反馈